HEADER PROTEIN BINDING 27-NOV-07 2JXO TITLE STRUCTURE OF THE SECOND PDZ DOMAIN OF NHERF-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EZRIN-RADIXIN-MOESIN-BINDING PHOSPHOPROTEIN 50; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PDZ 2 DOMAIN; COMPND 5 SYNONYM: EBP50, NA+, /H+, EXCHANGE REGULATORY COFACTOR NHE-RF, NHERF- COMPND 6 1, REGULATORY COFACTOR OF NA+, /H+, EXCHANGER, SODIUM-HYDROGEN COMPND 7 EXCHANGER REGULATORY FACTOR 1, SOLUTE CARRIER FAMILY 9 ISOFORM 3 COMPND 8 REGULATORY FACTOR 1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC9A3R1, NHERF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET 151/D-TOPO/PDZ2 KEYWDS NHERF-1, PDZ DOMAIN, PDZ2, ACETYLATION, CELL PROJECTION, MEMBRANE, KEYWDS 2 PHOSPHOPROTEIN, POLYMORPHISM, WNT SIGNALING PATHWAY, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 12 AUTHOR H.CHENG,J.LI,Z.DAI,Z.BU,H.RODER REVDAT 3 16-MAR-22 2JXO 1 REMARK SEQADV REVDAT 2 02-JUN-09 2JXO 1 JRNL REVDAT 1 09-DEC-08 2JXO 0 JRNL AUTH H.CHENG,J.LI,R.FAZLIEVA,Z.DAI,Z.BU,H.RODER JRNL TITL AUTOINHIBITORY INTERACTIONS BETWEEN THE PDZ2 AND C-TERMINAL JRNL TITL 2 DOMAINS IN THE SCAFFOLDING PROTEIN NHERF1 JRNL REF STRUCTURE V. 17 660 2009 JRNL REFN ISSN 0969-2126 JRNL PMID 19446522 JRNL DOI 10.1016/J.STR.2009.03.009 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : FELIX 2000, CNS 1.2 REMARK 3 AUTHORS : ACCELRYS SOFTWARE INC. (FELIX), BRUNGER, ADAMS, REMARK 3 CLORE, GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JXO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000100420. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288.1 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 0.15 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM PDZ2, HEPES, DTT, H2O, DSS, REMARK 210 95% H2O/5% D2O; 1 MM [U-100% 15N] REMARK 210 PDZ2, HEPES, DTT, H2O, DSS, 95% REMARK 210 H2O/5% D2O; 1 MM [U-100% 13C; U- REMARK 210 100% 15N] PDZ2, HEPES, DTT, H2O, REMARK 210 DSS, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-15N HSQC; 3D 1H-15N NOESY; REMARK 210 3D 1H-15N TOCSY; 3D HNHA; 3D REMARK 210 HNCO; 3D HNCACB; 3D HN(COCA)CB; REMARK 210 3D HCCH-COSY; 3D HCCH-TOCSY; 3D REMARK 210 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : FELIX 2000, SPARKY, CNS 1.2, REMARK 210 XWINNMR REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 12 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 148 157.96 159.86 REMARK 500 1 MET A 149 -55.21 -125.56 REMARK 500 1 ARG A 151 143.42 -29.34 REMARK 500 1 LYS A 159 -82.67 -51.29 REMARK 500 1 ASP A 171 -72.95 -130.25 REMARK 500 1 ALA A 195 161.14 -46.59 REMARK 500 1 GLN A 196 -13.92 82.73 REMARK 500 2 ARG A 151 152.31 -36.83 REMARK 500 2 LYS A 159 -80.40 -60.20 REMARK 500 2 ASP A 171 -74.52 -130.19 REMARK 500 3 THR A 148 150.24 158.32 REMARK 500 3 MET A 149 -52.86 -125.70 REMARK 500 3 LYS A 159 -78.15 -47.83 REMARK 500 3 ASP A 171 -64.39 -130.05 REMARK 500 4 THR A 148 132.05 158.37 REMARK 500 4 MET A 149 -57.42 -125.39 REMARK 500 4 ARG A 151 119.34 -24.73 REMARK 500 4 LYS A 159 -78.03 -73.97 REMARK 500 4 LYS A 174 -58.64 -122.21 REMARK 500 4 PRO A 175 -71.81 -81.28 REMARK 500 5 PHE A 147 -60.71 -106.70 REMARK 500 5 ARG A 151 159.98 -42.42 REMARK 500 5 LYS A 159 -88.73 -61.76 REMARK 500 5 ASP A 171 -77.23 -130.09 REMARK 500 5 GLN A 196 -0.22 74.81 REMARK 500 6 ASP A 145 104.26 -48.44 REMARK 500 6 ARG A 151 143.97 -28.53 REMARK 500 6 LYS A 159 -85.63 -55.76 REMARK 500 6 ASP A 171 -67.60 -130.33 REMARK 500 6 GLN A 196 -4.82 82.43 REMARK 500 6 PHE A 238 -70.82 -66.95 REMARK 500 7 THR A 148 129.51 161.50 REMARK 500 7 MET A 149 -57.94 -125.60 REMARK 500 7 LYS A 159 -78.68 -70.14 REMARK 500 7 ASP A 171 -71.09 -126.39 REMARK 500 8 PRO A 146 -70.05 -55.28 REMARK 500 8 PHE A 147 -60.72 -96.20 REMARK 500 8 THR A 148 128.82 168.83 REMARK 500 8 MET A 149 -65.57 -126.50 REMARK 500 8 LYS A 159 -80.18 -59.78 REMARK 500 8 GLN A 196 -17.04 82.46 REMARK 500 9 THR A 148 127.89 158.83 REMARK 500 9 MET A 149 -66.25 -127.16 REMARK 500 9 ARG A 151 121.87 -26.77 REMARK 500 9 LYS A 159 -78.99 -58.08 REMARK 500 9 ASP A 171 -78.73 -130.04 REMARK 500 9 GLN A 196 -3.05 77.55 REMARK 500 9 GLU A 208 99.25 -68.36 REMARK 500 9 LYS A 210 175.09 -54.96 REMARK 500 10 PHE A 147 -60.55 -107.30 REMARK 500 REMARK 500 THIS ENTRY HAS 67 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15567 RELATED DB: BMRB DBREF 2JXO A 150 240 UNP O14745 NHERF_HUMAN 150 240 SEQADV 2JXO GLY A 143 UNP O14745 EXPRESSION TAG SEQADV 2JXO ILE A 144 UNP O14745 EXPRESSION TAG SEQADV 2JXO ASP A 145 UNP O14745 EXPRESSION TAG SEQADV 2JXO PRO A 146 UNP O14745 EXPRESSION TAG SEQADV 2JXO PHE A 147 UNP O14745 EXPRESSION TAG SEQADV 2JXO THR A 148 UNP O14745 EXPRESSION TAG SEQADV 2JXO MET A 149 UNP O14745 EXPRESSION TAG SEQRES 1 A 98 GLY ILE ASP PRO PHE THR MET LEU ARG PRO ARG LEU CYS SEQRES 2 A 98 THR MET LYS LYS GLY PRO SER GLY TYR GLY PHE ASN LEU SEQRES 3 A 98 HIS SER ASP LYS SER LYS PRO GLY GLN PHE ILE ARG SER SEQRES 4 A 98 VAL ASP PRO ASP SER PRO ALA GLU ALA SER GLY LEU ARG SEQRES 5 A 98 ALA GLN ASP ARG ILE VAL GLU VAL ASN GLY VAL CYS MET SEQRES 6 A 98 GLU GLY LYS GLN HIS GLY ASP VAL VAL SER ALA ILE ARG SEQRES 7 A 98 ALA GLY GLY ASP GLU THR LYS LEU LEU VAL VAL ASP ARG SEQRES 8 A 98 GLU THR ASP GLU PHE PHE LYS HELIX 1 1 SER A 186 GLY A 192 1 7 HELIX 2 2 GLN A 211 ALA A 221 1 11 HELIX 3 3 ASP A 232 PHE A 239 1 8 SHEET 1 A 5 ARG A 153 LYS A 158 0 SHEET 2 A 5 GLU A 225 VAL A 230 -1 O VAL A 230 N ARG A 153 SHEET 3 A 5 ARG A 198 VAL A 202 -1 N VAL A 200 O LEU A 229 SHEET 4 A 5 GLN A 177 VAL A 182 -1 N GLN A 177 O ILE A 199 SHEET 5 A 5 PHE A 166 HIS A 169 -1 N ASN A 167 O SER A 181 SHEET 1 B 4 ARG A 153 LYS A 158 0 SHEET 2 B 4 GLU A 225 VAL A 230 -1 O VAL A 230 N ARG A 153 SHEET 3 B 4 ARG A 198 VAL A 202 -1 N VAL A 200 O LEU A 229 SHEET 4 B 4 VAL A 205 CYS A 206 -1 O VAL A 205 N VAL A 202 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1